Invesco NASDAQ Biotech UCITS ETF Acc
WKNA12CCJ
AssetklasseAktien
51,09€+0,19€
30.12.2025 12:47+0,37%
51,09€+0,19€
30.12.2025 12:47+0,37%
Eröffnung
50,83
Hoch
51,09
Tief
50,83
Umsatz
5.046,11
The Fund is a passively managed Exchange-Traded Fund (ETF), which aims to track the Total Return performance of the NASDAQ Biotechnology Index (the Index), less fees, expenses and transaction costs. The Index is designed to represent the performance of biotechnology and pharmaceutical securities on the NASDAQ Stock Market. The Fund does this through the use of unfunded swaps. The Index is a modified market capitalisation weighted index. The securities eligible for inclusion include common stocks, ordinary shares, ADRs and shares of beneficial interest or limited partnership interests.
Emittent
Invesco Investment Management Ltd
Benchmark
NASDAQ Biotechnology TR
Fondsgröße in Mio.
424,452
Gesamtkostenquote (TER)
0,4 %
Tracking Difference
3,2309
Replikation
Swap-basiert
Fondswährung
USD
Domizil
IE
Fondsauflage
-
Ausschüttung
Thesaurierend
Ausschüttungsintervall
-
NAV
59,389
NAV Datum
30.12.2025